drugset / Trial / NCT04331704

ANCHORS Alcohol & Sexual Health Study: UH3 Project

NCT04331704

RandomizedParallel-groupOpen-labelPrevention

Summary

80 young adult men will complete an initial survey and receive 1 of 2 types of alcohol and sexual health education and information to encourage prevention of alcohol-related problems, HIV and other sexually transmitted infections (STIs). Participants will then take pre-exposure prophylaxis (PrEP) for HIV prevention and complete a daily 5-minute, telephone-based interactive voice response (IVR) assessment of alcohol/substance use, sexual behavior and PrEP taking for 30 days. Medication will all be active PrEP. There is no placebo control in this study. Follow-up will occur after 30-days and 6-months later.

Timeline

Start
2021-01-12
Primary completion
2025-12-31
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Background Tenofovir disoproxil fumarate Small molecule 245 mg
Background emtricitabine Other / unclassified 200 mg